Craft

Venus MedTech

Stock Price

$5.6

2024-10-29

Market Capitalization

$2.5 B

2024-10-29

Revenue

¥470.8 M

FY, 2024

Venus MedTech Summary

Company Summary

Overview
Venus MedTech (启明医疗) is a company that develops and commercializes transcatheter heart valve medical devices. It provides products designed for transcatheter implantation to replace dysfunctional heart valves associated with aortic stenosis as well as pulmonic, mitral, and tricuspid regurgitation.
Type
Public
Status
Active
Founded
2009
HQ
Hangzhou Shi, CN | view all locations
Website
http://www.venusmedtech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

2 locations detected

  • Hangzhou Shi, Zhejiang Sheng HQ

    China

    311, 3 / f, block, 88 Jiangling Rd, Binjiang Qu

  • Hong Kong Island

    Hong Kong

    Sunlight Tower, Wan Chai

Venus MedTech Financials

Summary Financials

Revenue (H1, 2025)
¥187.1M
Gross profit (H1, 2025)
¥166.8M
Net income (H1, 2025)
(¥134.8M)
Cash (H1, 2025)
¥293.3M
EBIT (H1, 2025)
(¥135.4M)
Enterprise value
$2.7B

Footer menu